139 research outputs found
Dimensions of fluvial-tidal meanders: Are they disproportionally large?
This is the final version. Available from Geological Society of America via the DOI in this record.GSA Data Repository item 2018343, supplementary figures, tables, and a .kml file with the recorded polygons of fluvial-tidal meanders, is available online at http://www.geosociety.org/datarepository/2018/ or on request from [email protected] of the world’s major river systems seemingly have one or a few disproportionally large meanders, with tight bends, in the fluvial-tidal transition (e.g., the Thames in the UK, and the Salmon River in Canada). However, quantitative studies on meanders have so far primarily focused on rivers without tidal influence or on small tidal meanders without river inflow, providing relations between channel geometry and meander characteristics (length, amplitude, and sinuosity). Physics-based predictions of meander size and shape for the fluvial-tidal transition zone remain untested for a lack of data. Therefore, it remains unclear whether the dimensions of meanders in the fluvial-tidal transition zone are indeed disproportionally large, and whether meander characteristics can be used as an indicator for tidal influence. Here, data from 823 meanders in 68 fluvial-tidal transition zones worldwide are presented that reveal broad-brush relations between channel geometry and meander dimensions. Our results show that fluvial-tidal meanders indeed become larger in the seaward direction, but the dimensions are proportional to local channel width, as in rivers. Sinuosity maxima are an exception, rather than the rule, in the fluvial-tidal transition zone. Surprisingly, the width of the upstream river correlates with estuarine channel width and tidal meander size even though river discharge constitutes only a fraction of the tidal prism. The new scaling relations can be used to constrain dimensions of rivers and estuaries and their meanders.Dutch Technology Foundation Toegepaste en Technische Wetenschappe
Responsible and sustainable farm business: contextual duality as the moderating influence on entrepreneurial orientation
Future therapeutic targets in rheumatoid arthritis?
Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by persistent joint inflammation. Without adequate treatment, patients with RA will develop joint deformity and progressive functional impairment. With the implementation of treat-to-target strategies and availability of biologic therapies, the outcomes for patients with RA have significantly improved. However, the unmet need in the treatment of RA remains high as some patients do not respond sufficiently to the currently available agents, remission is not always achieved and refractory disease is not uncommon. With better understanding of the pathophysiology of RA, new therapeutic approaches are emerging. Apart from more selective Janus kinase inhibition, there is a great interest in the granulocyte macrophage-colony stimulating factor pathway, Bruton's tyrosine kinase pathway, phosphoinositide-3-kinase pathway, neural stimulation and dendritic cell-based therapeutics. In this review, we will discuss the therapeutic potential of these novel approaches
Alternative way to test the efficacy of swine FMD vaccines: measurement of pigs median infected dose (PID50) and regulation of live virus challenge dose
Foot-and -mouth disease to pigs is serious recently around the world. "Vaccination prevention" is still an important policy. OIE specifies 10,000 TCID50(0.2 ml) of virulent virus for challenge test in pigs to test the potency of FMD vaccine by intradermal route inoculating the virus in the heel bulbs of one foot or by intramuscular route administering into one site of the neck behind the ear. Convenience and speediness are available in the process of potency test of commercial FMD vaccine. We selected the route of "administering into one site of the muscular part of the neck behind the ear" because of convenience and speediness. However, it was difficult to infect control pigs even up to 100,000TCID50, so we changed the challenged virus from cell-passaged strain to suckling mice-passaged one, measured its PID50 (pigs median infected dose) and defined the virus challenge dose as 1000PID50. Meanwhile, we arranged the number of control pigs from two to three for easy evaluation
Durability of treatment effects of the Sleep Position Trainer versus oral appliance therapy in positional OSA: 12-month follow-up of a randomized controlled trial
The Sleep Position Trainer (SPT) is a new option for treating patients with positional obstructive sleep apnea (POSA). This study investigated long-term efficacy, adherence, and quality of life during use of the SPT device compared with oral appliance therapy (OAT) in patients with POSA. This prospective, multicenter trial randomized patients with mild to moderate POSA (apnea-hypopnea index [AHI] 5-30/h) to SPT or OAT. Polysomnography was performed at baseline and after 3 and 12 months' follow-up. The primary endpoint was OSA severity; adherence, quality of life, and adverse events were also assessed. Ninety-nine patients were randomized and 58 completed the study (29 in each group). Median AHI in the SPT group decreased from 13.2/h at baseline to 7.1/h after 12 months (P < 0.001); corresponding values in the OAT group were 13.4/h and 5.0/h (P < 0.001), with no significant between-group difference (P = 1.000). Improvements throughout the study were maintained at 12 months. Long-term median adherence was also similar in the two treatment groups; the proportion of patients who used their device for ≥ 4 h for 5 days in a week was 100% in the SPT group and 97.0% in the OAT group (P = 0.598). The efficacy of SPT therapy was maintained over 12 months and was comparable to that of OAT in patients with mild to moderate POSA. Adherence was relatively high, and similar in the two groups. www.clinicaltrials.gov (NCT02045576
Altered cyclophosphamide and thiotepa pharmacokinetics in a patient with moderate renal insufficiency
Commitment of cultural minorities in organizations:Effects of leadership and pressure to conform
PURPOSE: In this study, we investigated the commitment of cultural minorities and majorities in organizations. We examined how contextual factors, such as pressure to conform and leadership styles, affect the commitment of minority and majority members. DESIGN/METHODOLOGY/APPROACH: A field study was conducted on 107 employees in a large multinational corporation. FINDINGS: We hypothesize and found that cultural minorities felt more committed to the organization than majority members, thereby challenging the existing theoretical view that cultural minorities will feel less committed. We also found that organizational pressure to conform and effective leadership increased the commitment of minorities. IMPLICATIONS: Our findings indicate that organizational leaders and researchers should not only focus on increasing and maintaining the commitment of minority members, but should also consider how majority members react to cultural socialization and integration processes. The commitment of minority members can be further enhanced by effective leadership. ORIGINALITY/VALUE: In this study, we challenge the existing theoretical view based on similarity attraction theory and relational demography theory, that cultural minorities would feel less committed to the organization. Past research has mainly focused on minority groups, thereby ignoring the reaction of the majority to socialization processes. In this study, we show that cultural minorities can be more committed than majority members in organizations. Therefore, the perceptions of cultural majority members of socialization processes should also be considered in research on cultural diversity and acculturation
Neural correlates of evidence accumulation during value-based decisions revealed via simultaneous EEG-fMRI
Current computational accounts posit that, in simple binary choices, humans accumulate
evidence in favour of the different alternatives before committing to a decision. Neural
correlates of this accumulating activity have been found during perceptual decisions in
parietal and prefrontal cortex; however the source of such activity in value-based choices
remains unknown. Here we use simultaneous EEG–fMRI and computational modelling to
identify EEG signals reflecting an accumulation process and demonstrate that the within- and
across-trial variability in these signals explains fMRI responses in posterior-medial frontal
cortex. Consistent with its role in integrating the evidence prior to reaching a decision, this
region also exhibits task-dependent coupling with the ventromedial prefrontal cortex and
the striatum, brain areas known to encode the subjective value of the decision alternatives.
These results further endorse the proposition of an evidence accumulation process
during value-based decisions in humans and implicate the posterior-medial frontal cortex in
this process
Bright light therapy versus physical exercise to prevent co-morbid depression and obesity in adolescents and young adults with attention-deficit/hyperactivity disorder: study protocol for a randomized controlled trial
Background: The risk for major depression and obesity is increased in adolescents and adults with attention-deficit / hyperactivity disorder (ADHD) and adolescent ADHD predicts adult depression and obesity. Non-pharmacological interventions to treat and prevent these co-morbidities are urgently needed. Bright light therapy (BLT) improves day– night rhythm and is an emerging therapy for major depression. Exercise intervention (EI) reduces obesity and improves depressive symptoms. To date, no randomized controlled trial (RCT) has been performed to establish feasibility and efficacy of these interventions targeting the prevention of co-morbid depression and obesity in ADHD. We hypothesize that the two manualized interventions in combination with mobile health-based monitoring and reinforcement will result in less depressive symptoms and obesity compared to treatment as usual in adolescents and young adults with ADHD. Methods: This trial is a prospective, pilot phase-IIa, parallel-group RCT with three arms (two add-on treatment groups [BLT, EI] and one treatment as usual [TAU] control group). The primary outcome variable is change in the Inventory of Depressive Symptomatology total score (observer-blinded assessment) between baseline and ten weeks of intervention. This variable is analyzed with a mixed model for repeated measures approach investigating the treatment effect with respect to all three groups. A total of 330 participants with ADHD, aged 14 – < 30 years, will be screened at the four study centers. To establish effect sizes, the sample size was planned at the liberal significance level of α = 0.10 (two-sided) and the power of 1-β = 80% in order to find medium effects. Secondary outcomes measures including change in obesity, ADHD symptoms, general psychopathology, health-related quality of life, neurocognitive function, chronotype, and physical fitness are explored after the end of the intervention and at the 12-week follow-up. This is the first pilot RCT on the use of BLT and EI in combination with mobile health-based monitoring and reinforcement targeting the prevention of co-morbid depression and obesity in adolescents and young adults with ADHD. If at least medium effects can be established with regard to the prevention of depressive symptoms and obesity, a larger scale confirmatory phase-III trial may be warranted.The trial is funded by the EU Framework Programme for Research and
Innovation, Horizon 2020 (Project no. 667302). Funding period: January
2016–December 2020. This funding source had no role in the design of this
study and will not have any role during its execution, analyses, interpretation
of the data, or decision to submit results.
Some local funds additionally contributed to carry out this study, especially for
the preparation of the interventions: FBO research activity is by the Spanish
Ministry of Economy and Competitiveness – MINECO (RYC-2011-09011) and by
the University of Granada, Plan Propio de Investigación 2016, Excellence actions:
Unit of Excellence on Exercise and Health (UCEES)
- …